ANPCF News and Press, Angle Plc Ord From 01/19/23

Joseph Eid M.D., is a US certified medical oncologist with extensive experience of the use of biomarkers in clinical trials and as companion diagnostics Previous roles include senior positions in oncology at Bristol Myers Squibb, Merck & Co. and Hoffman-La Roche GUILDFORD, SURREY / A...

GUILDFORD, SURREY / ACCESSWIRE / January 11, 2023 / TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the Un...

Angle ( OTCQX:ANPCY ) said Tuesday that it plans to close its Canadian facilities, to streamline its operations and increase its cash runway. The company said it will close facilities in Toronto in an orderly wind down, and retains its facility in Pennsylvania as a centra...

ANGLE press release ( OTCPK:ANPCF ): 1H loss for the half-year £9.2M (H1 2021: £7.7M) reflecting planned investment. Cash and cash equivalents at 30 June 2022 of £20.5M (31 December 2021: £31.8M). Revenue of £0.4M (+33.3% Y/Y). For furth...

Angle (OTC:ANPCF) (OTCQX:ANPCY) said that the U.S. Food and Drug Administration (FDA) cleared Parsortix system for use in harvesting cancer cells from blood of patients with metastatic breast cancer (MBC) for subsequent analysis. The company said it is first ever FDA product clearan...

ANGLE plc (ANPCF): FY Revenue of £0.8M vs. eight months ended 31 December 2019of £0.6MCash and cash equivalents and short-term deposits combined balance at 31 December 2020 of £28.6MPress Release For further details see: ANGLE plc reports FY results